We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The acquisition, which is comprised of a $714 million cash payment and $81 million in net debt, is expected to close early in the fourth quarter. Read More
The microneedle works by creating controlled micro-injuries that spur the body’s natural wound-healing process while minimizing cellular damage. Read More
The clip-based therapy is a nonsurgical heart valve repair option that enables physicians to customize valve repairs based on the patient’s unique anatomy. Read More
The company said it redesigned the system by reshaping the mesh strip and relocating its initiator chemical, addressing common complaints in the FDA’s Manufacturer and User Facility Device Experience (MAUDE) database. Read More
“Patients who receive the XIENCE stent with shorter dual anti-platelet therapy durations do not have an increase in cardiac events and showed a reduction in severe bleeding, proving short dual anti-platelet therapy strategies with the XIENCE stent are safe in high bleeding-risk patients,” Abbott said. Read More
SmartCT includes software applications for angiography, neurology, soft-tissue imaging and guidewire/catheter navigation that support a wide range of procedures. Read More
The company’s second-generation version of its Pure-Vu System was previously cleared by the FDA for cleaning poorly prepared colons during colonoscopy procedures. Read More
According to the company, the test is 27 percent more accurate than mammography and has a 70 percent higher positive predictive value than thermography. Read More